InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
MGR | Ann: Appendix 3Y - Susan Lloyd-Hurwitz | 25/03/19 | 1 | 124 | |||
|
|||||||
MGR | Ann: Appendix 3Y - Peter Nash | 18/03/19 | 0 | 253 | |||
|
|||||||
MGR | Ann: Appendix 3Y - Samantha Mostyn | 18/03/19 | 0 | 125 | |||
|
|||||||
MGR | Ann: Change in substantial holding | 18/03/19 | 0 | 127 | |||
|
|||||||
MGR | Ann: Appendix 3B | 05/03/19 | 0 | 166 | |||
|
|||||||
MGR | Ann: Change in substantial holding | 21/02/19 | 0 | 163 | |||
|
|||||||
MGR | Ann: Dividend/Distribution - MGR | 09/02/19 | 6 | 1.5K | |||
|
|||||||
MGR | News: MGR UPDATE 1-Australia's Mirvac posts 39.4 pct rise in half-year profit | 07/02/19 | 0 | 122 | |||
|
See All Discussions